Loading clinical trials...
Loading clinical trials...
Post Marketing Surveillance Study To Observe Safety And Effectiveness Of Eraxis (Registered) Iv.
Conditions
Locations
10
South Korea
Chonbuk National University Hospital
Deokjin-gu, Jeollabuk-do, South Korea
Dong-A University Hospital
Busan, South Korea
Dong-A University Medical Center (Dong-A University Hospital)
Busen, South Korea
Keimyung University Dongsan Medical Center (KUDMC)
Daegu, South Korea
Daegu fatima hospital
Daegu, South Korea
Daegu Catholic University Medical Center (DCUMC)
Daegu, South Korea
Start Date
March 2, 2012
Primary Completion Date
May 20, 2016
Completion Date
May 20, 2016
Last Updated
November 21, 2018
NCT05421858
NCT04368559
NCT05178862
NCT06859671
NCT03363841
NCT03667690
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions